)
Respiratory
Driven by Our Promise
Congress Materials
- ERS 2022 | 4–6 Sep 2022 | View Materials
- ERS 2023 | 9–13 Sep 2023 | View Materials
Meet Us at an Event
| ERS 2024 | 7–11 Sep 2024 | Vienna, Austria | Details |
Expert Interviews
What is the Open Source Consortium (OSIC)?
Elizabeth Estes - USA
The importance of data repositories and potential future techniques for diagnosis and management of interstitial lung disease
Duration: 00:02:34
Diagnostic delay in interstitial lung disease (ILD)
Dr. Marlies Wijsenbeek - Netherlands
Dr. Wijsenbeek shares key clinical insights of managing patients with interstitial lung disease
Duration: 00:01:17
Gold standard endpoint for Alpha 1 Antitrypsin Deficiency (AATD)
Dr. Charlie Strange and Professor Gerry McElvaney - USA and Ireland
Importance of CT lung density as a preferential primary endpoint for Alpha 1 Antitrypsin Deficiency
Duration: 00:00:40
The role of patient organisations in rare lung diseases
Professor Daiana Stolz - Germany
The importance of involving patients and patient organisations in planning research and therapeutic decision making
Duration: 00:01:47
Our commitment to respiratory medicine
Professor Tobias Welte - Germany
Professor Tobias Welte highlights CSL Behring’s long-term commitment to respiratory medicine
Duration: 00:01:03
Diagnosing Alpha 1 Antitrypsin Deficiency (AATD)
Dr. Charlie Strange - USA
Dr. Strange discusses the importance of accurate and expedited diagnosis
Duration: 00:00:25
Self-administration in Alpha 1 Antitrypsin Deficiency (AATD) therapy
Dr. Robert Sandhaus - USA
Dr. Sandhaus shares real world evidence supporting self-administration.
Self-administration is currently only available in the EU and CH
Duration: 00:01:13
Pulmonary rehab for Alpha 1 patients
Dr. Rembert Koczulla - Germany
Dr. Koczulla explains what pulmonary rehabilitation can do for Alpha 1 Antitrypsin Deficiency patients
Duration: 00:01:32
Self-administration in Hereditary Angioedema (HAE)
Dr. Andrea Zanichelli - Italy
Dr. Zanichelli shares his experience with self-administration of a plasma-derived therapy
Duration: 00:00:59
Legend
- ERS, European Respiratory Society
CMD-NP-0197
Jul 2023